Your session is about to expire
← Back to Search
Smartphone App for Vaping Cessation
N/A
Waitlist Available
Led By Jaimee Heffner
Research Sponsored by Fred Hutchinson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 3 months post-randomization
Awards & highlights
Study Summary
This trial will study how well a digital program helps young adult e-cigarette users quit, to reduce risk of nicotine addiction and long-term health effects. #vaping #quitvaping
Who is the study for?
This trial is for young adults aged 18-30 in the US who use e-cigarettes at least weekly, own a smartphone (Android or iPhone), and have an email address. They must be willing to complete all study procedures and have a US mailing address.Check my eligibility
What is being tested?
The trial is testing 'ACT on Vaping,' a digital program designed to help young adult e-cigarette users quit vaping. It involves using a smartphone app, receiving text messages, and completing surveys.See study design
What are the potential side effects?
Since this intervention involves using a smartphone application and communication via text message rather than medication, traditional side effects are not expected. However, participants may experience stress or frustration related to quitting vaping.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in readiness to quit
Cotinine-confirmed 30-day point prevalence abstinence from all nicotine and tobacco
Overall treatment satisfaction rating
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm I (Act on Vaping app)Experimental Treatment3 Interventions
Participants receive supportive messages and use the ACT on Vaping smartphone app. They also receive incentivized text message check-ins assessing their vaping status.
Group II: Arm II (Incentivized text message check-ins)Active Control2 Interventions
Participants receive incentivized text messages check-ins assessing their vaping status.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smartphone app
2019
N/A
~130
Find a Location
Who is running the clinical trial?
Fred Hutchinson Cancer CenterLead Sponsor
556 Previous Clinical Trials
1,343,334 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,469 Previous Clinical Trials
2,619,348 Total Patients Enrolled
14 Trials studying Nicotine Addiction
2,069 Patients Enrolled for Nicotine Addiction
Jaimee HeffnerPrincipal InvestigatorFred Hutch/University of Washington Cancer Consortium
4 Previous Clinical Trials
445 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am between 18 and 30 years old.I am not using any tobacco cessation treatments at the time of screening.I have an email address.
Research Study Groups:
This trial has the following groups:- Group 1: Arm I (Act on Vaping app)
- Group 2: Arm II (Incentivized text message check-ins)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there an age limit for participants to qualify for this investigation?
"This clinical trial has a narrow age requirement, as only patients between 18 and 30 can be enrolled. By contrast, there are 10 studies for minors and 83 trials that cater to the elderly population."
Answered by AI
What are the eligibility requirements for participating in this clinical experiment?
"This study is limited to 60 participants aged 18-30 who are suffering from nicotine addiction."
Answered by AI
Are there any available slots in this clinical trial?
"Based on the information available through clinicaltrials.gov, this particular study is not presently recruiting candidates. It was initially posted on November 1st 2023 and has since been updated as of May 31st 2023. While it's currently full, there are 124 other medical trials that require participants right now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger